| Product Code: ETC5821326 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Mauritius continues to rely heavily on biologics imports, with key suppliers in 2024 being the UK, Denmark, South Africa, Sweden, and Seychelles. The high concentration of the Herfindahl-Hirschman Index (HHI) indicates a dominant market presence by these countries. The impressive Compound Annual Growth Rate (CAGR) of 61.4% from 2020 to 2024 reflects the increasing demand for biologics in Mauritius. Additionally, the remarkable growth rate of 87.52% from 2023 to 2024 suggests a rapid expansion of the market, potentially driven by evolving healthcare needs and advancements in biotechnology.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Biologics Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Biologics Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Biologics Market - Industry Life Cycle |
3.4 Mauritius Biologics Market - Porter's Five Forces |
3.5 Mauritius Biologics Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.6 Mauritius Biologics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Mauritius Biologics Market Revenues & Volume Share, By Disease? Category, 2021 & 2031F |
3.8 Mauritius Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2021 & 2031F |
4 Mauritius Biologics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius Biologics Market Trends |
6 Mauritius Biologics Market Segmentations |
6.1 Mauritius Biologics Market, By Source |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Biologics Market Revenues & Volume, By Microbial, 2021-2031F |
6.1.3 Mauritius Biologics Market Revenues & Volume, By Mammalian, 2021-2031F |
6.1.4 Mauritius Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.2 Mauritius Biologics Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2021-2031F |
6.2.3 Mauritius Biologics Market Revenues & Volume, By Vaccines, 2021-2031F |
6.2.4 Mauritius Biologics Market Revenues & Volume, By Recombinant Proteins, 2021-2031F |
6.2.5 Mauritius Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2021-2031F |
6.2.6 Mauritius Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.3 Mauritius Biologics Market, By Disease? Category |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Biologics Market Revenues & Volume, By Oncology, 2021-2031F |
6.3.3 Mauritius Biologics Market Revenues & Volume, By Infectious Diseases, 2021-2031F |
6.3.4 Mauritius Biologics Market Revenues & Volume, By Immunological Disorders, 2021-2031F |
6.3.5 Mauritius Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2021-2031F |
6.3.6 Mauritius Biologics Market Revenues & Volume, By Hematological Disorders, 2021-2031F |
6.3.7 Mauritius Biologics Market Revenues & Volume, By Others, 2021-2031F |
6.4 Mauritius Biologics Market, By Biologics Manufacturing |
6.4.1 Overview and Analysis |
6.4.2 Mauritius Biologics Market Revenues & Volume, By Outsourced, 2021-2031F |
6.4.3 Mauritius Biologics Market Revenues & Volume, By In-house, 2021-2031F |
7 Mauritius Biologics Market Import-Export Trade Statistics |
7.1 Mauritius Biologics Market Export to Major Countries |
7.2 Mauritius Biologics Market Imports from Major Countries |
8 Mauritius Biologics Market Key Performance Indicators |
9 Mauritius Biologics Market - Opportunity Assessment |
9.1 Mauritius Biologics Market Opportunity Assessment, By Source, 2021 & 2031F |
9.2 Mauritius Biologics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Mauritius Biologics Market Opportunity Assessment, By Disease? Category, 2021 & 2031F |
9.4 Mauritius Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2021 & 2031F |
10 Mauritius Biologics Market - Competitive Landscape |
10.1 Mauritius Biologics Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Biologics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here